Randomized, single-blind, crossover study to assess the pharmacokinetic and pharmacodynamic bioequivalence of CHS-1701 to pegfilgrastim in healthy subjects.

John A. Glaspy, Barbara Finck, Hong Tang et al.|Journal of Clinical Oncology|2017

Cited by 8